Association of regular aspirin use and breast cancer risk

Oncology

Volumn 68, Issue 1, 2005, Pages 40-47

  Swede, Helen ^a,b   Mirand, Amy L ^a   Menezes, Ravi J ^a   Moysich, Kirsten B ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Aspirin; Breast carcinogenesis; Chemoprevention; NSAIDs

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER DIAGNOSIS; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DRUG USE; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; BREAST TUMOR; CASE CONTROL STUDY; DOSE RESPONSE; MIDDLE AGED; RISK; STATISTICAL MODEL; TIME; UNITED STATES;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; RISK ASSESSMENT; TIME FACTORS; UNITED STATES;

EID: 18344376608     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084818     Document Type: Article

References (43)

1. Harris RE, Alshafie GA, Abou-Issa H, Seibert K: Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Res 2000;60:2101-2103.
2. Robertson FM, Parrett ML, Joarder FS, Ross M, Abou-Issa HM, Alshafie G, et al: Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas. Cancer Lett 1998;122:165-175.
3. Lee PP, Ip MM: Regulation of proliferation of rat mammary tumor cells by inhibitors of cyclooxygenase and lipoxygenase. Prostaglandins Leukot Essent Fatty Acids 1992;45:21-31.
4. Noguchi M, Earashi M, Minami M, Miyazaki I, Tanaka M, Sasaki T: Effects of piroxicam and esculetin on the MDA-MB-231 human breast cancer cell line. Prostaglandins Leukot Essent Fatty Acids 1995;53:325-329.
5. Vane JR, Bakhle YS, Botting RM: Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998;38:97-120.
6. Taketo MM: Cyclooxygenase-2 inhibitors in tumorigenesis (pt 1). J Natl Cancer Inst 1998;90:1529-1536.
7. Hwang D, Scollard D, Byrne J, Levine E: Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 1998;90:455-460.
8. Davies G, Martin LA, Sacks N, Dowsett M: Cyclooxygenase (COX-2), aromatase and breast cancer: A possible role for COX-2 inhibitors in breast cancer chemoprevention. Ann Oncol 2002;13:669-678.
9. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S: A hypothesis: Nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 1991;83:355-358.
10. Thun MJ, Henley SJ, Patrono C: Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 2002;94:252-266.
11. Muscat JE, Stellman SD, Wynder EL: Nonsteroidal anti-inflammatory drugs and colorectal cancer. Cancer 1994;74:1847-1854.
12. Reeves MJ, Newcomb PA, Trentham-Dietz A, Storer BE, Remington PL: Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 1996;5:955-960.
13. Martinez ME, McPherson RS, Levin B, Annegers JF: Aspirin and other nonsteroidal anti-inflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals. Cancer Epidemiol Biomarkers Prev 1995;4:703-707.
14. Patrignani P: Nonsteroidal anti-inflammatory drugs, COX-2 and colorectal cancer. Toxicol Lett 2000;112-113:493-498.
15. Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, et al: A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003;348:883-890.
16. Khuder SA, Mutgi AB: Breast cancer and NSAID use: A meta-analysis. Br J Cancer 2001;84:1188-1192.
17. Harris RE, Namboodiri K, Stellman SD, Wynder EL: Breast cancer and NSAID use: Heterogeneity in a case-control study. Prev Med 1995; 24:119-120.
18. Harris RE, Namboodiri KK, Farrar WB: Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology 1996;7:203-205.
19. Egan KM, Stampfer MJ, Giovannucci E, Rosner BA, Colditz GA: Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst 1996;88:988-993.
20. Coogan PF, Rao SR, Rosenberg L, Palmer JR, Strom BL, Zauber AG, et al: The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer. Prev Med 1999;29: 72-76.
21. Langman MJ, Cheng KK, Gilman EA, Lancashire RJ: Effect of anti-inflammatory drugs on overall risk of common cancer: Case-control study in general practice research database. BMJ 2000;320:1642-1646.
22. Sharpe CR, Collet JP, McNutt M, Belzile E, Boivin JF, Hanley JA: Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage. Br J Cancer 2000;83:112-120.
23. Paganini-Hill A: Aspirin and colorectal cancer: The Leisure World cohort revisited. Prev Med 1995;24:113-115.
24. Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW: Aspirin use and risk of fatal cancer. Cancer Res 1993;53:1322-1327.
25. Harris RE, Kasbari S, Farrar WB: Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. Oncol Rep 1999;6:71-73.
26. Schreinemachers DM, Everson RB: Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994;5:138-146.
27. Neugut AI, Rosenberg DJ, Ashan H, Jacobson JS, Wahid N, Hagan M, Rahman MI, Khan ZR, Chen L, Pablos-Mendez A, Shea S: Association between coronary heart disease and cancers of the breast, prostate, and colon. Cancer Epidemiol Biomarkers Prev 1998;7:869-873.
28. Cotterchio M, Kreiger N, Sloan M, Steingart A: Nonsteroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:1213-1217.
29. Rosenberg L: Nonsteroidal anti-inflammatory drugs and cancer. Prev Med 1995;24:107-109.
30. Friedman GD, Ury HK: Initial screening for carcinogenicity of commonly used drugs. J Natl Cancer Inst 1980;65:723-733.
31. Johnson TW, Anderson KE, Lazovich D, Folsom AR: Association of aspirin and nonsteroidal anti-inflammatory drug use and breast cancer. Cancer Epidemiol Biomarkers Prev 2002;11:1586-1591.
32. Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A: Breast cancer and nonsteroidal anti-inflammatory drugs: Prospective results from the Women's Health Initiative. Cancer Res 2003;63:6096-6101.
33. Moorman PG, Grubber JM, Millikan RC, Newman B: Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast. Cancer Causes Control 2003;14:915-922.
34. Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, Subbaramaih K, Dannenberg AJ, Neugut AI: Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA 2004;291:2433-2440.
35. Moysich KB, Mettlin C, Piver MS, Natarajan N, Menezes RJ, Swede H: Regular use of analgesic drugs and ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:903-906.
36. Moysich KB, Menezes RJ, Ronsani A, Swede H, Reid ME, Cummings KM, Falkner KL, Loewen G, Bepler G: Regular aspirin use and lung cancer risk. BMC Cancer 2002;2:31.
37. Schlesselman JJ: Case-Control Studies. New York, Oxford University Press, 1982, p 264.
38. Rosenberg L: Aspirin and breast cancer: No surprises yet. J Natl Cancer Inst 1996;88:941-942.
39. Rexrode KM, Lee IM, Cook NR, Hennekens CH, Buring JE: Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med 2000;9:19-27.
40. Suh O, Mettlin C, Petrelli N: Aspirin use, cancer, and polyps of the large bowel. Cancer 1993;72:1171-1177.
41. Mettlin C, Natarajan N, Huben R: Vasectomy and prostate cancer risk. Am J Epidemiol 1990;132:1056-1061.
42. Mettlin C: Milk drinking, other beverage habits, and lung cancer risk. Int J Cancer 1989;43:608-612.
43. Mettlin C, Croghan I, Natarajan N, Lane W: The association of age and familial risk in a case-control study of breast cancer. Am J Epidemiol 1990;131:973-983.